vs

Side-by-side financial comparison of Enact Holdings, Inc. (ACT) and OMNICELL, INC. (OMCL). Click either name above to swap in a different company.

Enact Holdings, Inc. is the larger business by last-quarter revenue ($312.7M vs $309.9M, roughly 1.0× OMNICELL, INC.). On growth, OMNICELL, INC. posted the faster year-over-year revenue change (14.9% vs 3.6%). Over the past eight quarters, OMNICELL, INC.'s revenue compounded faster (5.8% CAGR vs 3.6%).

Enact Holdings, Inc. is a leading U.S.-based private mortgage insurance provider. It delivers risk mitigation solutions to residential mortgage lenders, banks, and credit unions, enabling borrowers with smaller down payments to access affordable home financing, and supports sustainable homeownership for diverse consumer groups across the United States.

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

ACT vs OMCL — Head-to-Head

Bigger by revenue
ACT
ACT
1.0× larger
ACT
$312.7M
$309.9M
OMCL
Growing faster (revenue YoY)
OMCL
OMCL
+11.3% gap
OMCL
14.9%
3.6%
ACT
Faster 2-yr revenue CAGR
OMCL
OMCL
Annualised
OMCL
5.8%
3.6%
ACT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ACT
ACT
OMCL
OMCL
Revenue
$312.7M
$309.9M
Net Profit
$11.4M
Gross Margin
45.3%
Operating Margin
71.3%
60.1%
Net Margin
3.7%
Revenue YoY
3.6%
14.9%
Net Profit YoY
EPS (diluted)
$1.23
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACT
ACT
OMCL
OMCL
Q1 26
$309.9M
Q4 25
$312.7M
$314.0M
Q3 25
$311.5M
$310.6M
Q2 25
$304.9M
$290.6M
Q1 25
$306.8M
$269.7M
Q4 24
$301.8M
$306.9M
Q3 24
$309.6M
$282.4M
Q2 24
$298.8M
$276.8M
Net Profit
ACT
ACT
OMCL
OMCL
Q1 26
$11.4M
Q4 25
Q3 25
$5.5M
Q2 25
$5.6M
Q1 25
$-7.0M
Q4 24
Q3 24
$8.6M
Q2 24
$3.7M
Gross Margin
ACT
ACT
OMCL
OMCL
Q1 26
45.3%
Q4 25
41.5%
Q3 25
43.3%
Q2 25
43.9%
Q1 25
41.1%
Q4 24
46.2%
Q3 24
43.3%
Q2 24
41.3%
Operating Margin
ACT
ACT
OMCL
OMCL
Q1 26
60.1%
Q4 25
71.3%
0.1%
Q3 25
67.4%
2.7%
Q2 25
70.4%
2.8%
Q1 25
68.9%
-4.3%
Q4 24
68.9%
4.0%
Q3 24
74.1%
2.3%
Q2 24
78.6%
1.2%
Net Margin
ACT
ACT
OMCL
OMCL
Q1 26
3.7%
Q4 25
Q3 25
1.8%
Q2 25
1.9%
Q1 25
-2.6%
Q4 24
Q3 24
3.1%
Q2 24
1.3%
EPS (diluted)
ACT
ACT
OMCL
OMCL
Q1 26
$0.25
Q4 25
$1.23
$-0.05
Q3 25
$1.10
$0.12
Q2 25
$1.11
$0.12
Q1 25
$1.08
$-0.15
Q4 24
$1.05
$0.34
Q3 24
$1.15
$0.19
Q2 24
$1.16
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACT
ACT
OMCL
OMCL
Cash + ST InvestmentsLiquidity on hand
$582.5M
$239.2M
Total DebtLower is stronger
$744.5M
Stockholders' EquityBook value
$5.4B
$1.3B
Total Assets
$6.9B
$2.0B
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACT
ACT
OMCL
OMCL
Q1 26
$239.2M
Q4 25
$582.5M
$196.5M
Q3 25
$545.6M
$180.1M
Q2 25
$616.0M
$399.0M
Q1 25
$639.0M
$386.8M
Q4 24
$602.8M
$369.2M
Q3 24
$674.9M
$570.6M
Q2 24
$711.3M
$556.8M
Total Debt
ACT
ACT
OMCL
OMCL
Q1 26
Q4 25
$744.5M
Q3 25
$744.1M
Q2 25
$743.8M
Q1 25
$743.4M
Q4 24
$743.0M
Q3 24
$742.7M
Q2 24
$742.4M
Stockholders' Equity
ACT
ACT
OMCL
OMCL
Q1 26
$1.3B
Q4 25
$5.4B
$1.2B
Q3 25
$5.3B
$1.2B
Q2 25
$5.2B
$1.3B
Q1 25
$5.1B
$1.3B
Q4 24
$5.0B
$1.2B
Q3 24
$5.0B
$1.2B
Q2 24
$4.8B
$1.2B
Total Assets
ACT
ACT
OMCL
OMCL
Q1 26
$2.0B
Q4 25
$6.9B
$2.0B
Q3 25
$6.9B
$1.9B
Q2 25
$6.8B
$2.1B
Q1 25
$6.7B
$2.2B
Q4 24
$6.5B
$2.1B
Q3 24
$6.6B
$2.3B
Q2 24
$6.3B
$2.3B
Debt / Equity
ACT
ACT
OMCL
OMCL
Q1 26
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.14×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.15×
Q2 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACT
ACT
OMCL
OMCL
Operating Cash FlowLast quarter
$724.5M
$54.5M
Free Cash FlowOCF − Capex
$38.6M
FCF MarginFCF / Revenue
12.5%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
4.80×
TTM Free Cash FlowTrailing 4 quarters
$110.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACT
ACT
OMCL
OMCL
Q1 26
$54.5M
Q4 25
$724.5M
$30.4M
Q3 25
$192.0M
$28.3M
Q2 25
$119.5M
$42.8M
Q1 25
$226.7M
$25.9M
Q4 24
$686.3M
$56.3M
Q3 24
$188.1M
$22.8M
Q2 24
$144.7M
$58.7M
Free Cash Flow
ACT
ACT
OMCL
OMCL
Q1 26
$38.6M
Q4 25
$22.6M
Q3 25
$18.5M
Q2 25
$31.0M
Q1 25
$14.8M
Q4 24
$47.2M
Q3 24
$13.9M
Q2 24
$49.1M
FCF Margin
ACT
ACT
OMCL
OMCL
Q1 26
12.5%
Q4 25
7.2%
Q3 25
6.0%
Q2 25
10.7%
Q1 25
5.5%
Q4 24
15.4%
Q3 24
4.9%
Q2 24
17.8%
Capex Intensity
ACT
ACT
OMCL
OMCL
Q1 26
Q4 25
2.5%
Q3 25
3.1%
Q2 25
4.1%
Q1 25
4.1%
Q4 24
3.0%
Q3 24
3.1%
Q2 24
3.5%
Cash Conversion
ACT
ACT
OMCL
OMCL
Q1 26
4.80×
Q4 25
Q3 25
5.18×
Q2 25
7.58×
Q1 25
Q4 24
Q3 24
2.64×
Q2 24
15.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACT
ACT

Segment breakdown not available.

OMCL
OMCL

Product revenues$174.8M56%
Service revenues$135.1M44%

Related Comparisons